, the complexity of products which results in higher production costs with the fluctuation of production cost. 3. Selling expenses For year 2018, the selling expenses was 11.38 million baht compare to
IPD which generated highest margin comparing to other categories. Moreover, the efficient cost management such as medicine & medical supplies as well as the benefit from economy of scale in term of
profits stand at 31.43%, down from 34.90% due to foreign exchange fluctuations and the increase in energy costs. Total expenses were Baht 1,990.21 million, decreased by 4.46% and net profits reported at
of investment property 12.21 0.00 12.21 N/A 6.95% 0.00% Revenues from reduction of defaulted interest under the Court’s order 16.66 0.00 16.66 N/A 9.48% 0.00% Distribution costs (24.14 ) (26.13 ) (1.99
Gain (loss) on exchange rate 9,368 (5,944) (15,312) 257.60 Profit (loss) before Finance cost and Income Tax (23,472) (18,922) (4,550) 24.05 Finance Costs (4,135) (1,755) 2,380 (135.61) Profit (loss
partner who will give supports in term of financial and construction technology. This will also benefit on the cost reduction. 1Q18 Financial Highlight • Backlog1of the Company and its subsidiaries stood at
could played both weekdays and weekends. The Company was able to control operating costs. As a result, the Company could maintain its gross margin to be 40% same as last year. The Company could improve
-71.5% [Remark* Excludes foreign exchange rate effects and change in retirement benefit provisions.] Sales Revenue Consolidated sales revenue in Baht terms declined slightly to Bt2,992.8 million in 2Q19
* -58.0% Consol. Net Profit 255.1 159.0 268.6 +60.4% 559.7 -54.4% [ Remark * Excludes foreign exchange rate effects. ** Excludes foreign exchange rate effects and change in retirement benefit provisions
previous year because of its capability of better management of service costs. The net profit (loss) for the year 2019 reduced from the previous year is resulted from: 1. In the year 2019, the Company sold